The Rationale for Predictive Drug Metabolism

AdvanceTech Monitor
October 1, 2000
276 Pages - SKU: ATM186567
License type:

To purchase, check the box next to the section then click the "add section to cart" button. Learn more.

The Rationale for Predictive Drug Metabolism
  • Executive Summary (pp. 7-14) US $84.00
  • Introduction (pp. 15-21) US $68.00
  • Predictive Drug Metabolism - An FDA Perspective (pp. 22-40) US $173.00
  • The Use of LC/NMR to Elucidate the Structure of Drug Metabolites (pp. 41-57) US $103.00
  • Using Liquid Chromatography/Mass Spectrometry for Rapid Metabolic Screens During Drug Discovery (pp. 58-67) US $73.00
  • Hepatocytes as a Model for Assessing Drug Metabolism and Toxicity During Preclinical Drug Development (pp. 68-80) US $98.00
  • Metabolic Profiling, Reaction Phenotyping and Drug-Drug Interactions (pp. 81-93) US $93.00
  • In Vitro Prediction of Metabolic Drug-Drug Interactions (pp. 94-101) US $61.00
  • A Strategy for Use of In Vitro and In Vivo Metabolism Studies to Evaluate Potential Drug-Drug Interactions (pp. 102-113) US $82.00
  • The Use of High-Throughput Cytochrome P450 Inhibition Assays in Pharmaceutical Decision- Making (pp. 114-173) US $462.00
  • Using SSAR Data to Predict Metabolic Vulnerability (pp. 174-189) US $110.00
  • Computational Pharmacokinetics for Drug Discovery (pp. 190-200) US $90.00
  • Early Clinical Investigations to Identify and Evaluate the Potential for Drug- Drug Interactions (pp. 201-211) US $103.00
  • Pharmacogenomics-Based Metabolic Profiling During Clinical Trials (pp. 212-230) US $165.00
  • Bringing Pharmacogenomics to Drug Development (pp. 231-249) US $167.00
  • High-Performance Computing in Pharmaceutical R&D (pp. 250-261) US $85.00
  • Preclinical Assessment of Protein Drugs (pp. 262-278) US $139.00